Arch Biopartners Receives Health Canada Approval to Conduct : vimarsana.com

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it...

Related Keywords

Turkey , Canada , Toronto , Ontario , United States , Turkish , Canadian , , Arch Biopartners Inc , Health Canada , Drug Administration , Turkish Ministry Of Health , Biopartners Inc , Kidney Disease , Improving Global Outcomes , Turkish Ministry , Surgery Associated Acute Kidney Injury , Placebo Controlled Study , Acute Kidney Injury , Patients Undergoing On Pump Cardiac , Science Advances , National Research Council , Canada Industrial Research Assistance Program , Cardiac Surgery Associated Acute Kidney Injury , Arch Biopartner , Canadian Securities Administrator System , Electronic Document Analysis , Tsx Venture Exchange Arch , Rch Biopartners , Cute Kidney Injury Treatment , Stra Zeneca , Kd Breakthrough , Ilead , Laxo , Idney Foundation , Erck , Ordisk , Oche , Fizer Pbgi ,